Atlas Trials

Investigating the Potential Role of Aerosolized Retinoic Acid, a Potent Vitamin A Metabolite for Treating COVID-19 Anosmia and Retinoic Acid Insufficiency .A Novel Approach for Regaining Sense of Smell.

Clinical trial NCT05002530 · UNKNOWN

Trial details

NCT number
NCT05002530
Sponsor
Kafrelsheikh University
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Post COVID-19 Anosmia (Loss of Smell)
Start date
2021-11-01
Primary completion
2021-12-01
Enrollment
10000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.